| Old Articles: <Older 7511-7520 Newer> |
|---|
 |
The Motley Fool
June 7, 2011
Arundhati Parmar |
St. Jude Medical Introduces Two Cardiac Devices in India St. Jude heads to the Subcontinent.   |
The Motley Fool
June 6, 2011
Brian Orelli |
Big Pharma Tackles Lung Cancer; Biotech Helping, Too A big underserved market. |
The Motley Fool
June 6, 2011
Matt Koppenheffer |
Could Medtronic Double Your Money? Is it high time to add Medtronic's stock to your portfolio? |
The Motley Fool
June 6, 2011
Luke Timmerman |
Exelixis Zeroes In on Lead Drug, Sees Activity in the Bones of Prostate Cancer Patients Is Exelixis' risky bet about to pay off? |
The Motley Fool
June 4, 2011
Seth Jayson |
One Reason the Street Should Love SXC Health Solutions' Earnings SXC's cash conversion cycle figure has moved well below the average of the past eight quarters. This is good. |
The Motley Fool
June 3, 2011
Brian Orelli |
FDA Bullies Obesity Drugmakers It's been clear for some time that the Food and Drug Administration isn't particularly fond of obesity drugs. Now it's just being a bully. |
The Motley Fool
June 3, 2011
Brian Orelli |
Tag-Teaming Melanoma for Fun and Profit Bristol-Myers Squibb and Roche hook up. |
The Motley Fool
June 3, 2011
Luke Timmerman |
Orexigen, Facing High Hurdle at FDA, Puts Obesity Drug Development on Hold The close attention paid to safety makes this drug difficult to get right. |
The Motley Fool
June 3, 2011
Frank Vinluan |
GSK Sees Positive Results on Asthma, COPD Drug Expected to Succeed Advair GSK gets good news. |
BusinessWeek
June 2, 2011
Kresge & Connolly |
A New Pricing Game for Drugmakers in Europe Germany's new rules tying pharmaceutical prices to greater efficacy is worrying companies. |
| <Older 7511-7520 Newer> Return to current articles. |
